KuangChi Science Limited provided consolidated earning guidance for year ended 31 December 2023. For the year ended 31 December 2023, the Group expects that it may record a significant decrease in net loss for the year ended 31 December 2023 (?FY2023?) with a net loss ranging from approximately HKD 6,000,000 to HKD 8,000,000 for FY2023 as compared to a net loss of approximately HKD 67,912,000 for the year ended 31 December 2022 (?FY2022?). The expected decrease in the unaudited net loss of the Group is primarily attributable to: During the year, the Group disposed of its equity in Irisity AB, an overseas listed company, and recognized a loss on changes in fair value of approximately HKD 600,000 (FY2022: a loss on changes in fair value of approximately HKD 19,500,000); During FY2023, the Group improved its marketing strategy and further reduced its operating expenses through effective control, with a significant decrease in selling and marketing expenses of approximately HKD 19,700,000; and During FY2023, the Group continuously enhanced its internal control, strictly cut costs and increased efficiency, resulting in a significant decrease in administrative expenses of approximately HKD 10,000,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.68 HKD | +3.03% | +4.62% | -33.33% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.33% | 53.58M | |
-12.70% | 193B | |
+2.65% | 169B | |
+2.20% | 154B | |
+5.96% | 101B | |
+11.22% | 80.9B | |
+25.63% | 77.58B | |
-7.65% | 70.81B | |
-21.03% | 52.48B | |
-10.22% | 42.67B |
- Stock Market
- Equities
- 439 Stock
- News KuangChi Science Limited
- KuangChi Science Limited Provides Consolidated Earning Guidance for Year Ended 31 December 2023